Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0125 Transporter Info
Gene Name	SLC18B1
Transporter Name	MFS-type transporter SLC18B1
Gene ID	116843
UniProt ID	Q6NT16

Post-Translational Modification of This DT
Overview of SLC18B1 Modification Sites with Functional and Structural Information
Sequence	M E A L G D L E G P R A P G G D D P A G S A G E T P G W L S R E Q V F V L I S A A S V N L G S M M C Y S I L G P F F P K E A E K K G A S N T I I G M I F G C F A L F E L L A S L V F G N Y L V H I G A K F M F V A G M F V S G G V T I L F G V L D R V P D G P V F I A M C F L V R V M D A V S F A A A M T A S S S I L A K A F P N N V A T V L G S L E T F S G L G L I L G P P V G G F L Y Q S F G Y E V P F I V L G C V V L L M V P L N M Y I L P N Y E S D P G E H S F W K L I A L P K V G L I A F V I N S L S S C F G F L D P T L S L F V L E K F N L P A G Y V G L V F L G M A L S Y A I S S P L F G L L S D K R P P L R K W L L V F G N L I T A G C Y M L L G P V P I L H I K S Q L W L L V L I L V V S G L S A G M S I I P T F P E I L S C A H E N G F E E G L S T L G L V S G L F S A M W S I G A F M G P T L G G F L Y E K I G F E W A A A I Q G L W A L I S G L A M G L F Y L L E Y S R R K R S K S Q N I L S T E E E R T T L L P N E T
PTM type	X-Acetylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC18B1			[1]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC18B1 Methionine 1 has the potential to affect its expression or activity.
Phosphorylation
Serine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC18B1			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 21 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC18B1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	39
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 39 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC18B1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	42
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 42 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC18B1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 47 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC18B1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	52
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 52 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC18B1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	436
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 436 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC18B1			[2] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	438
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 438 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC18B1			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	443
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Serine 443 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC18B1			[6] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	444
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Threonine 444 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC18B1			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	51
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC18B1 Tyrosine 51 has the potential to affect its expression or activity.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC18B1			[10]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	437
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC18B1 Lysine 437 has the potential to affect its expression or activity.

References
1	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
2	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
3	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
4	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
5	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
6	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
7	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
8	Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction. J Proteomics. 2017 Aug 8;165:69-74.
9	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
10	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence